Skip to content

Abdominal acupoint stimulation with different waveforms of electroacupuncture for the treatment of simple obesity: randomized controlled trial

Abdominal acupoint stimulation with different waveforms of electroacupuncture for the treatment of simple obesity: randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000731
Enrollment
Unknown
Registered
2024-11-22
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Simple obesity

Interventions

Intermittent wave group:Intermittent wave electroacupuncture stimulation of abdominal acupoints
Sparse dense wave group:Electroacupuncture stimulation of abdominal acupoints with sparse and dense waves
Continuous wave group:Continuous wave electroacupuncture stimulation of abdominal acupoints

Sponsors

China Aerospace Science & Industry Corporation 731 Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria (1) Meets the Western diagnostic criteria for simple obesity mentioned above; (2) Age range: 20-55 years old, gender not limited; (3) Not receiving weight loss related treatment within the past 3 months and not participating in other clinical trials; (4) According to clinical data, obesity that is not caused by other diseases or drugs can be excluded; (5) Voluntarily cooperate with acupuncture treatment and sign an informed consent form. Only those who meet the above five criteria can be included.

Exclusion criteria

Exclusion criteria: Exclusion criteria (1) Secondary obesity caused by hypothalamic diseases, pituitary diseases, hypothyroidism, medication, etc; (2) Individuals with combined mental illnesses who are unable or unwilling to cooperate; (3) Women who are currently pregnant or breastfeeding; (4) Merge severe cardiovascular disease, cerebrovascular disease, liver and kidney dysfunction, hematological disease, and mental illness; (5) There are any contraindications of acupuncture and moxibustion, scars or infections at the application site, or the researchers think that there are systemic diseases at the application site that are not suitable for taking measures; (6) Participants in other clinical trials. Those who meet any of the above criteria cannot be included in the group.

Design outcomes

Primary

MeasureTime frame
Weight;4/10000 body mass index;

Secondary

MeasureTime frame
Body fat percentage;Body moisture content;hip circumference;waist circumference;

Countries

China

Contacts

Public ContactHanguanxiong

China Aerospace Science & Industry Corporation 731 Hospital

672289749@qq.com13931570486

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026